AMREP (NYSE:AXR – Get Free Report) issued its earnings results on Friday. The business services provider reported $0.75 EPS for the quarter, Zacks reports. AMREP had a return on equity of 8.05% and a net margin of 15.64%.
AMREP Price Performance
Shares of NYSE AXR opened at $36.18 on Friday. The company has a 50-day moving average price of $32.60 and a 200-day moving average price of $25.90. The stock has a market capitalization of $191.39 million, a P/E ratio of 20.69 and a beta of 0.92. AMREP has a 1 year low of $15.88 and a 1 year high of $39.67.
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered AMREP from a “buy” rating to a “hold” rating in a research report on Thursday.
Insider Buying and Selling
In related news, major shareholder James H. Dahl purchased 1,800 shares of the firm’s stock in a transaction that occurred on Friday, October 4th. The stock was acquired at an average price of $29.95 per share, for a total transaction of $53,910.00. Following the completion of the acquisition, the insider now owns 434,574 shares of the company’s stock, valued at $13,015,491.30. This represents a 0.42 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have acquired 6,800 shares of company stock worth $205,560 in the last quarter. Insiders own 37.60% of the company’s stock.
AMREP Company Profile
AMREP Corporation, through its subsidiaries, primarily engages in the real estate business. The company operates through two segments, Land Development and Homebuilding. It sells developed and undeveloped lots to homebuilders, commercial and industrial property developers, and others. In addition, the company owns mineral interests covering an area of approximately 55,000 surface acres of land in Sandoval County, New Mexico; and owns oil, gas, and minerals and mineral interests covering an area of approximately 147 surface acres of land in Brighton, Colorado.
See Also
- Five stocks we like better than AMREP
- What is the Hang Seng index?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- MarketBeat Week in Review – 12/9 – 12/13
- What is an Earnings Surprise?
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
Receive News & Ratings for AMREP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMREP and related companies with MarketBeat.com's FREE daily email newsletter.